High levels of Wilms' tumor 1 (WT1) expression were associated with aggressive clinical features in ovarian cancer

Z Liu, K Yamanouchi, T Ohtao, S Matsumura… - Anticancer …, 2014 - ar.iiarjournals.org
Aim: The aim of the present study was to evaluate the correlation between WT1 expression
levels and clinical features, to investigate the prognostic value of WT1 expression and to use …

Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer From the Danish “MALOVA” Ovarian Cancer Study

EVS Høgdall, L Christensen, SK Kjaer, J Blaakaer… - Gynecologic …, 2007 - Elsevier
OBJECTIVES.: To determine the WT1 expression level in tumor tissues from 774 women
with an epithelial ovarian tumor. Secondly, to evaluate whether WT1 tissue expression …

Correlation between WT1 expression and cell proliferation in endometrial cancer

S Dohi, S Ohno, Y Ohno, GI Soma, S Kyo… - Anticancer …, 2009 - ar.iiarjournals.org
Background: The Wilms' tumor gene WT1 is overexpressed in endometrial cancer. Although
recent studies have revealed that WT1 is a new prognostic factor, it remains unclear whether …

Immunohistochemical detection of WT1 protein in endometrial cancer

S Ohno, S Dohi, Y Ohno, S Kyo, H Sugiyama… - Anticancer …, 2009 - ar.iiarjournals.org
Background: The Wilms' tumor gene WT1 is overexpressed in various kinds of solid tumors.
However, it remains unclear whether WT1 plays a pathophysiological role in endometrial …

Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors

M Shimizu, T Toki, Y Takagi, I Konishi… - International journal of …, 2000 - journals.lww.com
The Wilms' tumor gene WT1 plays multiple roles in the development of the genitourinary
organs and Wilms' tumors. The aims of this study were to immunohistochemically evaluate …

Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis

T Sera, Y Hiasa, T Mashiba, Y Tokumoto… - European Journal of …, 2008 - Elsevier
BACKGROUND/AIMS: Wilms' tumour 1 gene (WT1) was originally isolated as a tumour-
suppressor gene. We investigated the expression of WT1 in hepatocellular carcinoma (HCC; …

Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma

S Yamamoto, H Tsuda, T Kita, K Maekawa, K Fujii… - Virchows Archiv, 2007 - Springer
Recently, oncogenic potential of the WT1 gene has been proposed in some human solid
tumors and leukemias. Although previous studies have shown the frequent expression of the …

Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer

B Hylander, E Repasky, P Shrikant, M Intengan… - Gynecologic …, 2006 - Elsevier
OBJECTIVES.: The identification of proteins that are selectively expressed in cancer and
with potential to elicit an immune response is the first step towards antigen-specific …

[HTML][HTML] WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study

W Netinatsunthorn, J Hanprasertpong, C Dechsukhum… - BMC cancer, 2006 - Springer
Background WT1 is a tumor suppressor gene responsible for Wilms' tumor. WT1 reactivity is
limited to ovarian serous carcinomas. Recent studies have shown that WT1 plays an …

Wilms tumor protein 1 (WT1)—not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma

ET Taube, C Denkert, J Sehouli, CA Kunze… - Gynecologic …, 2016 - Elsevier
Aims Wilms tumor protein 1 (WT1) expression is used in gynecological pathology as a
diagnostic marker of serous differentiation, and is frequently co-expressed with ER-α. Early …